October 14th, 20200(REUTERS) — Eli Lilly and Co. said on Tuesday that the government-sponsored clinical trial of its COVID-19 antibody treatment similar to one taken by President Trump has been paused by the U.S. government because of a safety concern.
Trump touted the Lilly drug, along with the antibody treatment from Regeneron Pharmaceuticals Inc....
April 29th, 20200WASHINGTON, D.C. – Top U.S. infectious disease official Dr. Anthony Fauci said Gilead Science Inc.'s experimental antiviral drug remdesivir will become the new standard of care for COVID-19 after results from a key clinical trial released Wednesday showed it help patients recover more quickly from the illness caused by the...
